Skip to main navigation Skip to search Skip to main content

Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

Research output: Contribution to journalArticle

Abstract

Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic
Original languageEnglish
Pages (from-to)1-3-3
JournalLEUKEMIA & LYMPHOMA
Issue number14
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • inglese

Fingerprint

Dive into the research topics of 'Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Cite this